GH-Pediatrics (posters) (posters)

SAT 028

Safety and Tolerability of Once-Weekly Administration of CTP-Modified Human Growth Hormone (MOD-4023): Phase 2 Study in Children with Growth Hormone Deficiency
Nataliya Zelinska, Violeta Iotova, Julia Skorodok, Oleg Malievsky, Ron G Rosenfeld, Zvi Zadik, Ronit Koren, Leanne Amitzi, Oren Hershkovitz, Gili Hart and Klaudziya Radziuk

SAT 029

SAT 031

Safety and Efficacy Evaluation of Human Growth Hormone (GH) Therapy in Patients with Idiopathic Short Stature (ISS) in Korea - a Randomized Controlled Trial
Min Ho Jung, Byung-Kyu Suh, Cheol Woo Ko, Kee-Hyoung Lee, Dong-Kyu Jin, Han-Wook Yoo, Jin Soon Hwang, Woo Yeong Chung, Heon-Seok Han, Vinay Prusty and Ho-Seong Kim

SAT 032

SAT 033

Can Growth Response in Turkish Patients with Idiopathic Growth Hormone Deficiency (IGHD) be Accurately Predicted Using the Kigs IGHD Prediction Models?
Oya Ercan, Anders Lindberg, Sukriye PINAR Isguven, Merih Berberoglu, Sule P Can, Ece Bober, Zeynep Sıklar, Sukran Darcan, Fatma Demirel, Feyza Darendeliler, Aysun Bideci, Bumin Nuri Dundar, Erdal Adal, Zehra Aycan, Saadet Olcay Evliyaoglu and Omer Faruk Tarim

SAT 034

Somapacitan (NNC0195-0092) a Novel Long Acting Human GH Derivative Binds Tightly, but Reversibly to Albumin in Plasma
Peter Thygesen, Gitte Konradsen, Christine Bruun Schjødt and Per Franklin Nielsen

SAT 035

SAT 036

Height Gain and Safety Outcomes in Growth Hormone-Treated Children with Idiopathic Short Stature: Experience from a Prospective Observational Study
Christopher J Child, Charmian A Quigley, Alan G Zimmermann, Cheri L Deal, Judith L. Ross, Ron G Rosenfeld, Gordon B Cutler Jr. and Werner F Blum

SAT 037

Changes in Height Standard Deviation (HSDS) Score and Growth Hormone (GH) Dose over 4 Years By Age at Treatment Start in Patients with Turner Syndrome (TS): Results from the Answer Program.
Philippe Backeljauw, Susan R Rose, Bradley Scott Miller, Peter A. Lee, Judith L. Ross, Ricardo Maamari, Chioma Uzoigwe and John Germak

SAT 038

Alkaline Phosphatase during Growth Hormone Treatment: A Reflection of Growth?
Lindsey Waldman, Marina E Goldis, Kristen M Williams, Christopher Joseph Romero, Elizabeth Burtman, Molly Oliver Regelmann, Elizabeth Wallach and Robert Rapaport

SAT 039

When Should IGF-1 be Monitored during Weekly Administration of a Long-Acting Human Growth Hormone (MOD-4023)?
Dennis M. Fisher, Michal Jaron Mendelson, Leanne Amitzi, Ronit Koren and Gili Hart

SAT 042

Ecos Study Analysis: Injection Settings and Adherence Data from Spain
Maria Dolores Rodríguez-Arnao, Amparo Rodríguez Sánchez, Rosario Peláez Muñoz, Ignacio Díez López, Joaquín Ramírez Fernándes, Jose Antonio Bermúdez de la Vega, Virginia Ballano, Ruari Duffy and Ekaterina B Koledova